| Aspect | Delirium | Major Neurocognitive Disorder |
|---|---|---|
| Definition | Acute reversible global cortical dysfunction | Chronic syndrome with multiple cognitive defects |
| Consciousness | Disturbed (reduced clarity of awareness) | Clear/intact |
| Onset | Acute/rapid (hours to days) | Insidious (months to years) |
| Course | Fluctuating with nocturnal worsening | Progressive and chronic |
| Duration | Days to weeks | Years |
| Reversibility | Usually reversible if cause treated | Mostly irreversible (15% reversible) |
| Attention | Severely impaired | Relatively preserved initially |
| Memory | Recent and immediate memory affected | Recent memory first, then remote |
| Hallucinations | Prominent (mainly visual) | Less common |
| Prognosis | Good if underlying cause treated | Progressive deterioration |
| Disorder | Severity | Consciousness | Functional Impact | Reversibility |
|---|---|---|---|---|
| Delirium | Variable | Disturbed | Severely impaired during episode | Usually reversible |
| Major NCD (Dementia) | Severe | Clear | Significantly impaired independence | Mostly irreversible |
| Mild NCD (MCI) | Mild | Clear | Preserved independence with effort | May progress to dementia |
| Amnestic Disorders | Specific to memory | Clear | Variable depending on severity | Variable |
| Condition | Prevalence | Age Groups | Gender Distribution |
|---|---|---|---|
| Delirium | 10% hospitalized patients, 30% ICU patients | Elderly and young children more susceptible | Equal in males and females |
| Major NCD | 5% over 65 years, 30% over 85 years | Increases with age | Variable by type |
| Alzheimer's Disease | 50-60% of all dementias | Late onset (>65) or early onset (<65) | Male:Female = 1:2 |
| Vascular Dementia | 15-30% of all dementias | Earlier onset than Alzheimer's | More common in males |
| Category | Delirium | Major NCD | Examples |
|---|---|---|---|
| Metabolic | Common cause | Common cause | Hypoxia, electrolyte imbalance, hepatic/renal failure |
| Infectious | Common cause | Less common | Meningitis, sepsis, UTI, HIV |
| Vascular | Common cause | Common cause | Stroke, heart failure, cerebrovascular disease |
| Traumatic | Common cause | Common cause | Head trauma, hematoma |
| Toxic/Substance | Very common | Common | Alcohol, drugs, heavy metals, CO poisoning |
| Degenerative | Rare | Most common | Alzheimer's, Parkinson's, Pick's disease |
| Nutritional | Common | Common | Thiamine, B12, folate deficiency |
| Type | Prevalence | Gender | Onset Pattern | Course | Key Features |
|---|---|---|---|---|---|
| Alzheimer's Disease | 50-60% | F>M (1:2) | Gradual | Progressive, 2-8 years | Memory loss, aphasia, apraxia, agnosia |
| Vascular Dementia | 15-30% | M>F | Acute or gradual | Stepwise progression | Focal neurological signs, patchy cognitive deficits |
| Lewy Body Dementia | 2nd most common neurodegenerative | Equal | Gradual | Progressive | Parkinsonism, visual hallucinations, delirium |
| Frontotemporal | Less common | Variable | Gradual | Progressive | Personality changes, language problems |
| Function | Delirium | Alzheimer's | Vascular Dementia | Lewy Body |
|---|---|---|---|---|
| Attention | Severely impaired | Mildly impaired initially | Variably impaired | Fluctuating |
| Memory | Recent/immediate affected | Recent first, then remote | Patchy impairment | Variable |
| Executive Function | Severely impaired | Progressively impaired | Early impairment | Fluctuating |
| Language | Disorganized | Aphasia develops | Variable | Relatively preserved |
| Visuospatial | Impaired | Progressively impaired | Variable | Early impairment |
| Orientation | Time first, then place/person | Progressively impaired | Variable | Fluctuating |
| Feature | Delirium | Alzheimer's | Vascular Dementia | Lewy Body |
|---|---|---|---|---|
| Onset | Acute (hours-days) | Insidious (months-years) | Acute or stepwise | Gradual |
| Fluctuation | Marked diurnal variation | Minimal | Stepwise | Marked fluctuation |
| Hallucinations | Visual prominent | Less common | Variable | Visual hallucinations prominent |
| Motor Features | Variable | Late motor problems | Focal deficits | Early parkinsonism |
| Sleep | Disturbed sleep-wake cycle | Sleep disturbances | Variable | Sleep disorders common |
| Behavior | Agitated/hyperactive or hypoactive | Progressive behavioral changes | Variable | Behavioral fluctuations |
| Risk Factor | Delirium | Alzheimer's | Vascular Dementia |
|---|---|---|---|
| Age | Elderly more susceptible | Increasing age | Increasing age |
| Gender | Equal | Female predominance | Male predominance |
| Cardiovascular | Predisposing factor | Hypertension, diabetes | Major risk factor |
| Education | Not specific | Lower education | Variable |
| Genetics | Not significant | Familial in 40% | Less significant |
| Lifestyle | Hospitalization | Sedentary lifestyle | Vascular risk factors |
| Medical Conditions | Multiple medical issues | Depression, diabetes | Stroke, heart disease |
| Treatment Type | Delirium | Alzheimer's | Vascular Dementia | Lewy Body |
|---|---|---|---|---|
| Primary Treatment | Treat underlying cause | Cholinesterase inhibitors | Prevent further strokes | Cholinesterase inhibitors |
| Symptomatic | Haloperidol, risperidone | Memantine, antipsychotics | Antihypertensives | Levodopa (cautiously) |
| Environmental | Optimum sensory environment | Safe, calm environment | Structured environment | Consistent routine |
| Supportive | Fluid/nutrition support | Physical/psychological rehab | Cardiovascular risk reduction | Fall prevention |
| Reversibility | Often reversible | Mostly irreversible | Partially preventable | Irreversible |
| Drug Category | Examples | Mechanism | Indications | Side Effects |
|---|---|---|---|---|
| Cholinesterase Inhibitors | Donepezil (Aricept), Galantamine (Reminyl), Rivastigmine (Exelon) | Increase acetylcholine | Mild to moderate dementia | GI upset, bradycardia, dizziness |
| NMDA Antagonists | Memantine | Glutamate antagonist | Moderate to severe dementia | Dizziness, confusion, headache |
| Antipsychotics | Haloperidol, Risperidone | Dopamine antagonist | Behavioral symptoms | Extrapyramidal symptoms |
| Anxiolytics | Benzodiazepines | GABA enhancement | Agitation, anxiety | Sedation, falls risk |
| Criterion | Delirium | Major NCD | Mild NCD |
|---|---|---|---|
| Consciousness | Disturbed | Clear | Clear |
| Cognitive Decline | Acute fluctuating | Significant from previous level | Modest decline |
| Functional Impact | Severe during episode | Interferes with independence | Preserved independence |
| Duration | Hours to days | Progressive over months/years | Stable or slowly progressive |
| Reversibility | Usually reversible | Mostly irreversible | May progress to dementia |
| Associated Features | Hallucinations, agitation | Neurological signs | Compensatory strategies needed |
| Condition | Short-term Prognosis | Long-term Prognosis | Factors Affecting Outcome |
|---|---|---|---|
| Delirium | Good if cause treated | Usually full recovery | Early recognition and treatment |
| Alzheimer's | Progressive decline | Death in 2-8 years | Age of onset, severity |
| Vascular Dementia | Stepwise decline | Variable | Cardiovascular risk control |
| Lewy Body | Fluctuating course | Progressive decline | Early recognition, medication management |
| Mild NCD | Variable | 10-15% progress to dementia annually | Underlying cause, risk factors |
| Strategy | Delirium | Alzheimer's | Vascular Dementia |
|---|---|---|---|
| Primary Prevention | Avoid precipitating factors | Lifestyle modifications | Cardiovascular risk reduction |
| Risk Factor Control | Medication review | Exercise, diet, social engagement | Hypertension, diabetes control |
| Environmental | Optimize hospital environment | Cognitive stimulation | Safe environment |
| Medications | Avoid anticholinergics | No proven preventive drugs | Antihypertensives, statins |
| Monitoring | High-risk patient identification | Regular cognitive assessment | Stroke prevention |
| Condition | Indications | Goals | Duration |
|---|---|---|---|
| Delirium | Severe agitation, safety concerns | Stabilization, cause identification | Days to weeks |
| Severe Dementia | Behavioral problems, safety | Symptom management, placement | Variable |
| Mild NCD | Rarely needed | Diagnostic workup | Short-term |
| Reversible Causes | Urgent medical conditions | Treat underlying cause | Variable |
| Support Type | Delirium | Major NCD | Mild NCD |
|---|---|---|---|
| Patient Support | Reorientation, reassurance | Structured activities, routine | Cognitive strategies |
| Family Support | Education about condition | Caregiver training | Early planning |
| Community Resources | Hospital-based | Day care centers, nursing homes | Support groups |
| Psychotherapy | Not typically used | Reminiscence therapy, music therapy | Cognitive behavioral therapy |
| Long-term Planning | Recovery focused | End-of-life planning | Advance directives |
| Assessment | Delirium | Dementia | Purpose |
|---|---|---|---|
| Cognitive Testing | Mini-Mental State Exam | Neuropsychological battery | Severity assessment |
| Functional Assessment | Activities of daily living | Instrumental ADLs | Independence level |
| Behavioral Assessment | Agitation scales | Behavioral rating scales | Symptom management |
| Laboratory | Complete metabolic panel | Reversible cause workup | Identify treatable causes |
| Imaging | Usually not needed acutely | MRI/CT for structural changes | Differential diagnosis |
These comprehensive comparison tables provide a systematic overview of organic brain syndromes and neurocognitive disorders, making it easier to understand the key differences, similarities, and clinical approaches for each condition.